<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;fc=20230708114047&amp;v=2.18.0.post9+e462414&amp;utm_source=Chrome&amp;ff=20250210151054&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;fc=20230708114047&amp;v=2.18.0.post9+e462414&amp;utm_source=Chrome&amp;ff=20250210151054&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Mon, 10 Feb 2025 20:10:55 +0000</lastbuilddate>
<pubDate>Mon, 10 Feb 2025 06:00:00 -0500</pubDate>
<ttl>120</ttl>
<item>
<title>Tricuspid and mitral regurgitation after mitral transcatheter edge-to-edge repair: a complex interplay</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39928369/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250210151054&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Feb 10:ehaf044. doi: 10.1093/eurheartj/ehaf044. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39928369/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250210151054&v=2.18.0.post9+e462414">39928369</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf044>10.1093/eurheartj/ehaf044</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39928369</guid>
<pubDate>Mon, 10 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Domenico Angellotti</dc:creator>
<dc:creator>Fabien Praz</dc:creator>
<dc:creator>Stephan Windecker</dc:creator>
<dc:date>2025-02-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Tricuspid and mitral regurgitation after mitral transcatheter edge-to-edge repair: a complex interplay</dc:title>
<dc:identifier>pmid:39928369</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf044</dc:identifier>
</item>
<item>
<title>Meet the team: new EHJ Editors Matthias Endres, Ulrich Laufs, and Ranil De Silva</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39928367/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250210151054&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Feb 10:ehae929. doi: 10.1093/eurheartj/ehae929. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39928367/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250210151054&v=2.18.0.post9+e462414">39928367</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae929>10.1093/eurheartj/ehae929</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39928367</guid>
<pubDate>Mon, 10 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Judith Ozkan</dc:creator>
<dc:date>2025-02-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Meet the team: new EHJ Editors Matthias Endres, Ulrich Laufs, and Ranil De Silva</dc:title>
<dc:identifier>pmid:39928367</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae929</dc:identifier>
</item>
<item>
<title>Prognosis following acute myocardial infarction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39928355/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250210151054&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Feb 10:ehaf056. doi: 10.1093/eurheartj/ehaf056. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39928355/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250210151054&v=2.18.0.post9+e462414">39928355</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf056>10.1093/eurheartj/ehaf056</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39928355</guid>
<pubDate>Mon, 10 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Iain B Squire</dc:creator>
<dc:creator>Shirley Sze</dc:creator>
<dc:date>2025-02-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Prognosis following acute myocardial infarction</dc:title>
<dc:identifier>pmid:39928355</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf056</dc:identifier>
</item>
<item>
<title>Pseudoxanthoma elasticum with cardiovascular involvement</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39928354/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250210151054&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Feb 10:ehaf022. doi: 10.1093/eurheartj/ehaf022. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39928354/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250210151054&v=2.18.0.post9+e462414">39928354</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf022>10.1093/eurheartj/ehaf022</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39928354</guid>
<pubDate>Mon, 10 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Tadahiro Kugai</dc:creator>
<dc:creator>Nobuhiro Tahara</dc:creator>
<dc:creator>Yoshihiro Fukumoto</dc:creator>
<dc:date>2025-02-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Pseudoxanthoma elasticum with cardiovascular involvement</dc:title>
<dc:identifier>pmid:39928354</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf022</dc:identifier>
</item>
<item>
<title>Atrial cardiomyocyte-restricted cleavage of gasdermin D promotes atrial arrhythmogenesis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39927987/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250210151054&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: These findings establish a unique pyroptosis-independent role of NT-GSDMD in ACMs and arrhythmogenesis, which involves ROS-driven mitochondrial dysfunction. Mitochondrial-targeted therapy, either by reducing ROS production or inhibition of GSDMD, prevents AF inducibility, positioning GSDMD as a novel therapeutic target for AF prevention.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Feb 10:ehaf024. doi: 10.1093/eurheartj/ehaf024. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Enhanced inflammatory signalling causally contributes to atrial fibrillation (AF) development. Gasdermin D (GSDMD) is an important downstream effector of several inflammasome pathways. However, the role of GSDMD, particularly the cleaved N-terminal (NT)-GSDMD, in non-immune cells remains elusive. This study aimed to elucidate the function of NT-GSDMD in atrial cardiomyocytes (ACMs) and determine its contribution to atrial arrhythmogenesis.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Human atrial appendages were used to assess the protein levels and localization. A modified adeno-associated virus 9 was employed to establish ACM-restricted overexpression of NT-GSDMD in mice.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The cleavage of GSDMD was enhanced in ACMs of AF patients. Atrial cardiomyocyte-restricted overexpression of NT-GSDMD in mice increased susceptibility to pacing-induced AF. The NT-GSDMD pore formation facilitated interleukin-1β secretion from ACMs, promoting macrophage infiltration, while up-regulating 'endosomal sorting complexes required for transport'-mediated membrane-repair mechanisms, which prevented inflammatory cell death (pyroptosis) in ACMs. Up-regulated NT-GSDMD directly targeted mitochondria, increasing mitochondrial reactive oxygen species (ROS) generation, which triggered proarrhythmic calcium-release events. The NT-GSDMD-induced arrhythmogenesis was mitigated by the mitochondrial-specific antioxidant MitoTEMPO. A mutant NT-GSDMD lacking pore-formation capability failed to cause mitochondrial dysfunction or induce atrial arrhythmia. Genetic ablation of Gsdmd prevented spontaneous AF development in a mouse model.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: These findings establish a unique pyroptosis-independent role of NT-GSDMD in ACMs and arrhythmogenesis, which involves ROS-driven mitochondrial dysfunction. Mitochondrial-targeted therapy, either by reducing ROS production or inhibition of GSDMD, prevents AF inducibility, positioning GSDMD as a novel therapeutic target for AF prevention.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39927987/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250210151054&v=2.18.0.post9+e462414">39927987</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf024>10.1093/eurheartj/ehaf024</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39927987</guid>
<pubDate>Mon, 10 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Yue Yuan</dc:creator>
<dc:creator>Pascal Martsch</dc:creator>
<dc:creator>Xiaohui Chen</dc:creator>
<dc:creator>Enrique Martinez</dc:creator>
<dc:creator>Luge Li</dc:creator>
<dc:creator>Jia Song</dc:creator>
<dc:creator>Theresa Poppenborg</dc:creator>
<dc:creator>Florian Bruns</dc:creator>
<dc:creator>Jong Hwan Kim</dc:creator>
<dc:creator>Markus Kamler</dc:creator>
<dc:creator>James F Martin</dc:creator>
<dc:creator>Issam Abu-Taha</dc:creator>
<dc:creator>Dobromir Dobrev</dc:creator>
<dc:creator>Na Li</dc:creator>
<dc:date>2025-02-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Atrial cardiomyocyte-restricted cleavage of gasdermin D promotes atrial arrhythmogenesis</dc:title>
<dc:identifier>pmid:39927987</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf024</dc:identifier>
</item>
<item>
<title>Wildfires, Compound Extreme Events, Climate Change, and Cardiovascular Health</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39927913/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250210151054&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2025 Jan 21:S0735-1097(25)00136-6. doi: 10.1016/j.jacc.2025.01.009. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39927913/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250210151054&v=2.18.0.post9+e462414">39927913</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2025.01.009>10.1016/j.jacc.2025.01.009</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39927913</guid>
<pubDate>Mon, 10 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Kai Chen</dc:creator>
<dc:creator>Yuan Lu</dc:creator>
<dc:creator>Harlan M Krumholz</dc:creator>
<dc:date>2025-02-10</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Wildfires, Compound Extreme Events, Climate Change, and Cardiovascular Health</dc:title>
<dc:identifier>pmid:39927913</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2025.01.009</dc:identifier>
</item>
<item>
<title>Exploring Origin-Dependent Susceptibility of Smooth Muscle Cells to Aortic Diseases Through Intersectional Genetics</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39925267/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250210151054&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Our approach to genetically targeting SMC subtypes provides a novel platform for exploring origin-dependent or location-specific aortic vascular diseases. This genetic system enables comprehensive analysis of contributions from different cell lineages to SMC behavior and pathology, thereby paving the way for targeted research and therapeutic interventions in the future.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Feb 10. doi: 10.1161/CIRCULATIONAHA.124.070782. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: The developmental diversity among smooth muscle cells (SMCs) plays a crucial role in segment-specific aortic diseases. However, traditional genetic approaches are inadequate for enabling in vivo analysis of disease susceptibility associated with cellular origin. There is an urgent need to build genetic technologies that target different developmental origins to investigate the mechanisms of aortopathies, thereby facilitating the development of effective therapeutics.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: To address this challenge, we developed an advanced dual recombinase-mediated intersectional genetic system, specifically designed to precisely target SMCs from various developmental origins in mice. Specifically, we used <i>Isl1-Dre</i>, <i>Wnt1-Dre</i>, <i>Meox1-DreER</i>, and <i>Upk3b-Dre</i> to target SMC progenitors from the second heart field, cardiac neural crest, somites, and mesothelium, respectively. This system was combined with single-cell RNA sequencing to investigate the impact of TGF-β (transforming growth factor-β) signaling in different segments of the aorta by selectively knocking out Tgfbr2 in the ascending aorta and Smad4 in the aortic arch, respectively.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Through intersectional genetic approaches, we use the <i>Myh11-Cre(ER</i>) driver along with origin-specific Dre drivers to trace cells of diverse developmental origins within the SMC population. We found that a deficiency of Tgfbr2 in SMCs of the ascending aorta leads to aneurysm formation in this specific region. We also demonstrate the critical role of Smad4 in preserving aortic wall integrity and homeostasis in SMCs of the aortic arch.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Our approach to genetically targeting SMC subtypes provides a novel platform for exploring origin-dependent or location-specific aortic vascular diseases. This genetic system enables comprehensive analysis of contributions from different cell lineages to SMC behavior and pathology, thereby paving the way for targeted research and therapeutic interventions in the future.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39925267/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250210151054&v=2.18.0.post9+e462414">39925267</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.070782>10.1161/CIRCULATIONAHA.124.070782</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39925267</guid>
<pubDate>Mon, 10 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Ximeng Han</dc:creator>
<dc:creator>Yi Li</dc:creator>
<dc:creator>Enci Wang</dc:creator>
<dc:creator>Huan Zhu</dc:creator>
<dc:creator>Xiuzhen Huang</dc:creator>
<dc:creator>Wenjuan Pu</dc:creator>
<dc:creator>Mingjun Zhang</dc:creator>
<dc:creator>Kuo Liu</dc:creator>
<dc:creator>Huan Zhao</dc:creator>
<dc:creator>Zixin Liu</dc:creator>
<dc:creator>Yufei Zhao</dc:creator>
<dc:creator>Linghong Shen</dc:creator>
<dc:creator>Yan Li</dc:creator>
<dc:creator>Xiao Yang</dc:creator>
<dc:creator>Qing-Dong Wang</dc:creator>
<dc:creator>Xin Ma</dc:creator>
<dc:creator>Ruling Shen</dc:creator>
<dc:creator>Kathy Lui</dc:creator>
<dc:creator>Lixin Wang</dc:creator>
<dc:creator>Ben He</dc:creator>
<dc:creator>Bin Zhou</dc:creator>
<dc:date>2025-02-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Exploring Origin-Dependent Susceptibility of Smooth Muscle Cells to Aortic Diseases Through Intersectional Genetics</dc:title>
<dc:identifier>pmid:39925267</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.070782</dc:identifier>
</item>
<item>
<title>European Heart Agency: 12-year European Society of Cardiology presence in Brussels</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39923810/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250210151054&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Feb 10:ehae879. doi: 10.1093/eurheartj/ehae879. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39923810/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250210151054&v=2.18.0.post9+e462414">39923810</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae879>10.1093/eurheartj/ehae879</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39923810</guid>
<pubDate>Sun, 09 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Panos E Vardas</dc:creator>
<dc:date>2025-02-09</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>European Heart Agency: 12-year European Society of Cardiology presence in Brussels</dc:title>
<dc:identifier>pmid:39923810</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae879</dc:identifier>
</item>
<item>
<title>Molecular basis of convergent evolution of ACE2 receptor utilization among HKU5 coronaviruses</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39922192/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250210151054&amp;v=2.18.0.post9+e462414
      <description>DPP4 was considered a canonical receptor for merbecoviruses until the recent discovery of African bat-borne MERS-related coronaviruses using ACE2. The extent and diversity of ACE2 utilization among merbecoviruses and their receptor species tropism remain unknown. Here, we reveal that HKU5 enters host cells utilizing Pipistrellus abramus (P.abr) and several non-bat mammalian ACE2s through a binding mode distinct from that of any other known ACE2-using coronaviruses. We defined the molecular...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Feb 3:S0092-8674(24)01475-2. doi: 10.1016/j.cell.2024.12.032. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DPP4 was considered a canonical receptor for merbecoviruses until the recent discovery of African bat-borne MERS-related coronaviruses using ACE2. The extent and diversity of ACE2 utilization among merbecoviruses and their receptor species tropism remain unknown. Here, we reveal that HKU5 enters host cells utilizing Pipistrellus abramus (P.abr) and several non-bat mammalian ACE2s through a binding mode distinct from that of any other known ACE2-using coronaviruses. We defined the molecular determinants of receptor species tropism and identified a single amino acid mutation enabling HKU5 to utilize human ACE2, providing proof of principle for machine-learning-assisted outbreak preparedness. We show that MERS-CoV and HKU5 have markedly distinct antigenicity and identified several HKU5 inhibitors, including two clinical compounds. Our findings profoundly alter our understanding of coronavirus evolution, as several merbecovirus clades independently evolved ACE2 utilization, and pave the way for developing countermeasures against viruses poised for human emergence.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39922192/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250210151054&v=2.18.0.post9+e462414">39922192</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.12.032>10.1016/j.cell.2024.12.032</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39922192</guid>
<pubDate>Sat, 08 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Young-Jun Park</dc:creator>
<dc:creator>Chen Liu</dc:creator>
<dc:creator>Jimin Lee</dc:creator>
<dc:creator>Jack T Brown</dc:creator>
<dc:creator>Cheng-Bao Ma</dc:creator>
<dc:creator>Peng Liu</dc:creator>
<dc:creator>Risako Gen</dc:creator>
<dc:creator>Qing Xiong</dc:creator>
<dc:creator>Samantha K Zepeda</dc:creator>
<dc:creator>Cameron Stewart</dc:creator>
<dc:creator>Amin Addetia</dc:creator>
<dc:creator>Caroline J Craig</dc:creator>
<dc:creator>M Alejandra Tortorici</dc:creator>
<dc:creator>Abeer N Alshukairi</dc:creator>
<dc:creator>Tyler N Starr</dc:creator>
<dc:creator>Huan Yan</dc:creator>
<dc:creator>David Veesler</dc:creator>
<dc:date>2025-02-08</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Molecular basis of convergent evolution of ACE2 receptor utilization among HKU5 coronaviruses</dc:title>
<dc:identifier>pmid:39922192</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.12.032</dc:identifier>
</item>
<item>
<title>Multiple independent acquisitions of ACE2 usage in MERS-related coronaviruses</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39922191/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250210151054&amp;v=2.18.0.post9+e462414
      <description>The angiotensin-converting enzyme 2 (ACE2) receptor is shared by various coronaviruses with distinct receptor-binding domain (RBD) architectures, yet our understanding of these convergent acquisition events remains elusive. Here, we report that two bat MERS-related coronaviruses (MERSr-CoVs) infecting Pipistrellus nathusii (P.nat)-MOW15-22 and PnNL2018B-use ACE2 as their receptor, with narrow ortholog specificity. Cryoelectron microscopy structures of the MOW15-22/PnNL2018B RBD-ACE2 complexes...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Feb 4:S0092-8674(24)01474-0. doi: 10.1016/j.cell.2024.12.031. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The angiotensin-converting enzyme 2 (ACE2) receptor is shared by various coronaviruses with distinct receptor-binding domain (RBD) architectures, yet our understanding of these convergent acquisition events remains elusive. Here, we report that two bat MERS-related coronaviruses (MERSr-CoVs) infecting Pipistrellus nathusii (P.nat)-MOW15-22 and PnNL2018B-use ACE2 as their receptor, with narrow ortholog specificity. Cryoelectron microscopy structures of the MOW15-22/PnNL2018B RBD-ACE2 complexes unveil an unexpected and entirely distinct binding mode, mapping >;45 Å away from that of any other known ACE2-using coronaviruses. Functional profiling of ACE2 orthologs from 105 mammalian species led to the identification of host tropism determinants, including an ACE2 N432-glycosylation restricting viral recognition, and the design of a soluble P.nat ACE2 mutant with potent viral neutralizing activity. Our findings reveal convergent acquisition of ACE2 usage for merbecoviruses found in European bats, underscoring the extraordinary diversity of ACE2 recognition modes among coronaviruses and the promiscuity of this receptor.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39922191/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250210151054&v=2.18.0.post9+e462414">39922191</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.12.031>10.1016/j.cell.2024.12.031</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39922191</guid>
<pubDate>Sat, 08 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Cheng-Bao Ma</dc:creator>
<dc:creator>Chen Liu</dc:creator>
<dc:creator>Young-Jun Park</dc:creator>
<dc:creator>Jingjing Tang</dc:creator>
<dc:creator>Jing Chen</dc:creator>
<dc:creator>Qing Xiong</dc:creator>
<dc:creator>Jimin Lee</dc:creator>
<dc:creator>Cameron Stewart</dc:creator>
<dc:creator>Daniel Asarnow</dc:creator>
<dc:creator>Jack Brown</dc:creator>
<dc:creator>M Alejandra Tortorici</dc:creator>
<dc:creator>Xiao Yang</dc:creator>
<dc:creator>Ye-Hui Sun</dc:creator>
<dc:creator>Yuan-Mei Chen</dc:creator>
<dc:creator>Xiao Yu</dc:creator>
<dc:creator>Jun-Yu Si</dc:creator>
<dc:creator>Peng Liu</dc:creator>
<dc:creator>Fei Tong</dc:creator>
<dc:creator>Mei-Ling Huang</dc:creator>
<dc:creator>Jing Li</dc:creator>
<dc:creator>Zheng-Li Shi</dc:creator>
<dc:creator>Zengqin Deng</dc:creator>
<dc:creator>David Veesler</dc:creator>
<dc:creator>Huan Yan</dc:creator>
<dc:date>2025-02-08</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Multiple independent acquisitions of ACE2 usage in MERS-related coronaviruses</dc:title>
<dc:identifier>pmid:39922191</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.12.031</dc:identifier>
</item>
<item>
<title>Novel pharmacological approaches to lowering blood pressure and managing hypertension</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39920248/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250210151054&amp;v=2.18.0.post9+e462414
      <description>Hypertension is the leading cause of death globally, primarily due to its strong association with cardiovascular disease. The global prevalence of hypertension has surged over the past three decades, driven by rising rates of diabetes mellitus and obesity. Despite current antihypertensive therapies, only a small proportion of patients with hypertension achieve adequate blood pressure control, necessitating novel therapeutic strategies. In this Review we explore the challenges and emerging...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2025 Feb 7. doi: 10.1038/s41569-025-01131-4. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Hypertension is the leading cause of death globally, primarily due to its strong association with cardiovascular disease. The global prevalence of hypertension has surged over the past three decades, driven by rising rates of diabetes mellitus and obesity. Despite current antihypertensive therapies, only a small proportion of patients with hypertension achieve adequate blood pressure control, necessitating novel therapeutic strategies. In this Review we explore the challenges and emerging opportunities in hypertension management. Aprocitentan, a dual endothelin receptor antagonist, is the first agent from a novel class of antihypertensive drug to be licensed since 2007 and exemplifies innovative treatments on the horizon. Here we also address the complex factors contributing to poor hypertension control, including genetic influences, lifestyle factors, therapeutic inertia and poor patient adherence. We discuss the limitations of existing therapies and highlight promising new pharmacological approaches to hypertension management. Integrating these novel treatments alongside current pharmaceuticals combined with improved diagnostic and management strategies could substantially reduce the global burden of hypertension and associated cardiovascular disease.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39920248/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250210151054&v=2.18.0.post9+e462414">39920248</a> | DOI:<a href=https://doi.org/10.1038/s41569-025-01131-4>10.1038/s41569-025-01131-4</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39920248</guid>
<pubDate>Fri, 07 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Matthew Sayer</dc:creator>
<dc:creator>David J Webb</dc:creator>
<dc:creator>Neeraj Dhaun</dc:creator>
<dc:date>2025-02-07</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Novel pharmacological approaches to lowering blood pressure and managing hypertension</dc:title>
<dc:identifier>pmid:39920248</dc:identifier>
<dc:identifier>doi:10.1038/s41569-025-01131-4</dc:identifier>
</item>
<item>
<title>Tracing the roots of cardiac fibrosis: role of endothelial-to-mesenchymal transition</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39920247/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250210151054&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2025 Feb 7. doi: 10.1038/s41569-025-01134-1. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39920247/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250210151054&v=2.18.0.post9+e462414">39920247</a> | DOI:<a href=https://doi.org/10.1038/s41569-025-01134-1>10.1038/s41569-025-01134-1</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39920247</guid>
<pubDate>Fri, 07 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Elizabeth Figueroa-Juárez</dc:creator>
<dc:date>2025-02-07</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Tracing the roots of cardiac fibrosis: role of endothelial-to-mesenchymal transition</dc:title>
<dc:identifier>pmid:39920247</dc:identifier>
<dc:identifier>doi:10.1038/s41569-025-01134-1</dc:identifier>
</item>
<item>
<title>Vagal circuits in the heart and gut can regulate cardiometabolism and stress responses</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39920246/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250210151054&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2025 Feb 7. doi: 10.1038/s41569-025-01133-2. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39920246/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250210151054&v=2.18.0.post9+e462414">39920246</a> | DOI:<a href=https://doi.org/10.1038/s41569-025-01133-2>10.1038/s41569-025-01133-2</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39920246</guid>
<pubDate>Fri, 07 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Karina Huynh</dc:creator>
<dc:date>2025-02-07</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Vagal circuits in the heart and gut can regulate cardiometabolism and stress responses</dc:title>
<dc:identifier>pmid:39920246</dc:identifier>
<dc:identifier>doi:10.1038/s41569-025-01133-2</dc:identifier>
</item>
<item>
<title>GUK1 activation is a metabolic liability in lung cancer</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39919745/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250210151054&amp;v=2.18.0.post9+e462414
      <description>Little is known about metabolic vulnerabilities in oncogene-driven lung cancer. Here, we perform a phosphoproteomic screen in anaplastic lymphoma kinase (ALK)-rearranged ("ALK+") patient-derived cell lines and identify guanylate kinase 1 (GUK1), a guanosine diphosphate (GDP)-synthesizing enzyme, as a target of ALK signaling in lung cancer. We demonstrate that ALK binds to and phosphorylates GUK1 at tyrosine 74 (Y74), resulting in increased GDP biosynthesis. Spatial imaging of ALK+ patient tumor...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Jan 28:S0092-8674(25)00093-5. doi: 10.1016/j.cell.2025.01.024. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Little is known about metabolic vulnerabilities in oncogene-driven lung cancer. Here, we perform a phosphoproteomic screen in anaplastic lymphoma kinase (ALK)-rearranged ("ALK+") patient-derived cell lines and identify guanylate kinase 1 (GUK1), a guanosine diphosphate (GDP)-synthesizing enzyme, as a target of ALK signaling in lung cancer. We demonstrate that ALK binds to and phosphorylates GUK1 at tyrosine 74 (Y74), resulting in increased GDP biosynthesis. Spatial imaging of ALK+ patient tumor specimens shows enhanced phosphorylation of GUK1 that significantly correlates with guanine nucleotides in situ. Abrogation of GUK1 phosphorylation reduces intracellular GDP and guanosine triphosphate (GTP) pools and decreases mitogen-activated protein kinase (MAPK) signaling and Ras-GTP loading. A GUK1 variant that cannot be phosphorylated (Y74F) decreases tumor proliferation in vitro and in vivo. Beyond ALK, other oncogenic fusion proteins in lung cancer also regulate GUK1 phosphorylation. These studies may pave the way for the development of new therapeutic approaches by exploiting metabolic dependencies in oncogene-driven lung cancers.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39919745/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250210151054&v=2.18.0.post9+e462414">39919745</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2025.01.024>10.1016/j.cell.2025.01.024</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39919745</guid>
<pubDate>Fri, 07 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Jaime L Schneider</dc:creator>
<dc:creator>Kiran Kurmi</dc:creator>
<dc:creator>Yutong Dai</dc:creator>
<dc:creator>Ishita Dhiman</dc:creator>
<dc:creator>Shakchhi Joshi</dc:creator>
<dc:creator>Brandon M Gassaway</dc:creator>
<dc:creator>Christian W Johnson</dc:creator>
<dc:creator>Nicole Jones</dc:creator>
<dc:creator>Zongyu Li</dc:creator>
<dc:creator>Christian P Joschko</dc:creator>
<dc:creator>Toshio Fujino</dc:creator>
<dc:creator>Joao A Paulo</dc:creator>
<dc:creator>Satoshi Yoda</dc:creator>
<dc:creator>Gerard Baquer</dc:creator>
<dc:creator>Daniela Ruiz</dc:creator>
<dc:creator>Sylwia A Stopka</dc:creator>
<dc:creator>Liam Kelley</dc:creator>
<dc:creator>Andrew Do</dc:creator>
<dc:creator>Mari Mino-Kenudson</dc:creator>
<dc:creator>Lecia V Sequist</dc:creator>
<dc:creator>Jessica J Lin</dc:creator>
<dc:creator>Nathalie Y R Agar</dc:creator>
<dc:creator>Steven P Gygi</dc:creator>
<dc:creator>Kevin M Haigis</dc:creator>
<dc:creator>Aaron N Hata</dc:creator>
<dc:creator>Marcia C Haigis</dc:creator>
<dc:date>2025-02-07</dc:date>
<dc:source>Cell</dc:source>
<dc:title>GUK1 activation is a metabolic liability in lung cancer</dc:title>
<dc:identifier>pmid:39919745</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2025.01.024</dc:identifier>
</item>
<item>
<title>Tumor "age" in early-onset colorectal cancer</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39919707/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250210151054&amp;v=2.18.0.post9+e462414
      <description>The incidence of early-onset colorectal cancer (EO-CRC) is surging, and by 2030, one-third of all CRCs will occur before the commonly recommended screening age of 50 years. The time required for EO-CRC to reach the metastatic stage is unknown, yet this knowledge is critical to tailor early-diagnosis screening strategies. Here, we discuss how defining a key biological feature of EO-CRC may be central to protecting young adults from an alarming and probably unprecedented tumor epidemic.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Feb 6;188(3):589-593. doi: 10.1016/j.cell.2024.12.003.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The incidence of early-onset colorectal cancer (EO-CRC) is surging, and by 2030, one-third of all CRCs will occur before the commonly recommended screening age of 50 years. The time required for EO-CRC to reach the metastatic stage is unknown, yet this knowledge is critical to tailor early-diagnosis screening strategies. Here, we discuss how defining a key biological feature of EO-CRC may be central to protecting young adults from an alarming and probably unprecedented tumor epidemic.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39919707/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250210151054&v=2.18.0.post9+e462414">39919707</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.12.003>10.1016/j.cell.2024.12.003</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39919707</guid>
<pubDate>Fri, 07 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Gianluca Mauri</dc:creator>
<dc:creator>Giorgio Patelli</dc:creator>
<dc:creator>Giovanni Crisafulli</dc:creator>
<dc:creator>Salvatore Siena</dc:creator>
<dc:creator>Alberto Bardelli</dc:creator>
<dc:date>2025-02-07</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Tumor "age" in early-onset colorectal cancer</dc:title>
<dc:identifier>pmid:39919707</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.12.003</dc:identifier>
</item>
<item>
<title>Inspiring the next generation of engineers and scientists to be champions of equitable change</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39919706/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250210151054&amp;v=2.18.0.post9+e462414
      <description>Nyasha Milanzi is a winner of the fifth annual Rising Black Scientists Awards for a scholar in the physical, data, earth, and environmental sciences. We asked emerging Black scientists to tell us about their scientific vision and goals, experiences that sparked their interest in science, how they want to contribute to a more inclusive scientific community, and how these all fit together on their journey. This is her story.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Feb 6;188(3):586-588. doi: 10.1016/j.cell.2025.01.014.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Nyasha Milanzi is a winner of the fifth annual Rising Black Scientists Awards for a scholar in the physical, data, earth, and environmental sciences. We asked emerging Black scientists to tell us about their scientific vision and goals, experiences that sparked their interest in science, how they want to contribute to a more inclusive scientific community, and how these all fit together on their journey. This is her story.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39919706/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250210151054&v=2.18.0.post9+e462414">39919706</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2025.01.014>10.1016/j.cell.2025.01.014</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39919706</guid>
<pubDate>Fri, 07 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Nyasha Milanzi</dc:creator>
<dc:date>2025-02-07</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Inspiring the next generation of engineers and scientists to be champions of equitable change</dc:title>
<dc:identifier>pmid:39919706</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2025.01.014</dc:identifier>
</item>
<item>
<title>Retooling science: Transforming tools into instruments of equity as a Black physician-scientist</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39919705/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250210151054&amp;v=2.18.0.post9+e462414
      <description>Victor Ekuta is a winner of the fifth annual Rising Black Scientists Awards for a scholar in the life and health sciences. We asked emerging Black scientists to tell us about their scientific vision and goals, the experiences that sparked their interest in science, how they want to contribute to a more inclusive scientific community, and how these all fit together on their journey. This is his story.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Feb 6;188(3):582-584. doi: 10.1016/j.cell.2025.01.010.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Victor Ekuta is a winner of the fifth annual Rising Black Scientists Awards for a scholar in the life and health sciences. We asked emerging Black scientists to tell us about their scientific vision and goals, the experiences that sparked their interest in science, how they want to contribute to a more inclusive scientific community, and how these all fit together on their journey. This is his story.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39919705/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250210151054&v=2.18.0.post9+e462414">39919705</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2025.01.010>10.1016/j.cell.2025.01.010</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39919705</guid>
<pubDate>Fri, 07 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Victor Ekuta</dc:creator>
<dc:date>2025-02-07</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Retooling science: Transforming tools into instruments of equity as a Black physician-scientist</dc:title>
<dc:identifier>pmid:39919705</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2025.01.010</dc:identifier>
</item>
<item>
<title>Bridging worlds: A STEM journey from Nigeria to the US and back</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39919704/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250210151054&amp;v=2.18.0.post9+e462414
      <description>Kenna Gloria Agbugba is a winner of the fifth annual Rising Black Scientists Awards for a scholar in the physical, data, earth, and environmental sciences. We asked emerging Black scientists to tell us about their scientific vision and goals, the experiences that sparked their interest in science, how they want to contribute to a more inclusive scientific community, and how these all fit together on their journey. This is her story.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Feb 6;188(3):578-580. doi: 10.1016/j.cell.2025.01.013.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Kenna Gloria Agbugba is a winner of the fifth annual Rising Black Scientists Awards for a scholar in the physical, data, earth, and environmental sciences. We asked emerging Black scientists to tell us about their scientific vision and goals, the experiences that sparked their interest in science, how they want to contribute to a more inclusive scientific community, and how these all fit together on their journey. This is her story.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39919704/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250210151054&v=2.18.0.post9+e462414">39919704</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2025.01.013>10.1016/j.cell.2025.01.013</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39919704</guid>
<pubDate>Fri, 07 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Kenna Gloria Agbugba</dc:creator>
<dc:date>2025-02-07</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Bridging worlds: A STEM journey from Nigeria to the US and back</dc:title>
<dc:identifier>pmid:39919704</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2025.01.013</dc:identifier>
</item>
<item>
<title>The sounds of music: Tracing memories and pathways through research and resistance</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39919703/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250210151054&amp;v=2.18.0.post9+e462414
      <description>Jheannelle Johnson is a winner of the fifth annual Rising Black Scientists Awards for a scholar in the life and health sciences. We asked emerging Black scientists to tell us about their scientific vision and goals, experiences that sparked their interest in science, how they want to contribute to a more inclusive scientific community, and how these all fit together on their journey. This is her story.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Feb 6;188(3):574-576. doi: 10.1016/j.cell.2025.01.009.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Jheannelle Johnson is a winner of the fifth annual Rising Black Scientists Awards for a scholar in the life and health sciences. We asked emerging Black scientists to tell us about their scientific vision and goals, experiences that sparked their interest in science, how they want to contribute to a more inclusive scientific community, and how these all fit together on their journey. This is her story.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39919703/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250210151054&v=2.18.0.post9+e462414">39919703</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2025.01.009>10.1016/j.cell.2025.01.009</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39919703</guid>
<pubDate>Fri, 07 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Jheannelle Johnson</dc:creator>
<dc:date>2025-02-07</dc:date>
<dc:source>Cell</dc:source>
<dc:title>The sounds of music: Tracing memories and pathways through research and resistance</dc:title>
<dc:identifier>pmid:39919703</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2025.01.009</dc:identifier>
</item>
<item>
<title>New light shed on sex-related risk factors and frailty</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39918852/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250210151054&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Feb 7;46(6):493-496. doi: 10.1093/eurheartj/ehae932.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39918852/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250210151054&v=2.18.0.post9+e462414">39918852</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae932>10.1093/eurheartj/ehae932</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39918852</guid>
<pubDate>Fri, 07 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2025-02-07</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>New light shed on sex-related risk factors and frailty</dc:title>
<dc:identifier>pmid:39918852</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae932</dc:identifier>
</item>
<item>
<title>Correction to: Atheroma transcriptomics identifies ARNTL as a smooth muscle cell regulator and with clinical and genetic data improves risk stratification</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39918843/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250210151054&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Feb 7:ehaf107. doi: 10.1093/eurheartj/ehaf107. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39918843/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250210151054&v=2.18.0.post9+e462414">39918843</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf107>10.1093/eurheartj/ehaf107</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39918843</guid>
<pubDate>Fri, 07 Feb 2025 06:00:00 -0500</pubDate>
<dc:date>2025-02-07</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Correction to: Atheroma transcriptomics identifies ARNTL as a smooth muscle cell regulator and with clinical and genetic data improves risk stratification</dc:title>
<dc:identifier>pmid:39918843</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf107</dc:identifier>
</item>





























</channel>
</rss>